Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.36 USD | +3.33% | -0.93% | +26.69% |
05-09 | ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.69% | 4.4B | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+5.07% | 22.67B | |
-9.63% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- IBRX Stock
- News ImmunityBio, Inc.
- Transcript : ImmunityBio, Inc., NantKwest, Inc. - M&A Call